Julia Marie Eastland - May 26, 2023 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
Director
Signature
Julia M. Eastland, by /s/ Trevor Dutcher, Attorney-in-Fact
Stock symbol
DVAX
Transactions as of
May 26, 2023
Transactions value $
$0
Form type
4
Date filed
5/31/2023, 05:23 PM
Previous filing
Mar 27, 2023
Next filing
Nov 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Award $0 +5.36K +100% $0.00 10.7K May 26, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Stock Option (Right to Buy) Award $0 +22.5K $0.00 22.5K May 26, 2023 Common Stock 22.5K $11.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company. The reporting person has reported prior awards of restricted stock units in Table II on Form 4. The total reported in Column 5 includes 5,357 newly awarded restricted stock units and 5,357 restricted stock units previously reported in Table II.
F2 This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.